4888 Share Price Performance
JP¥0
-320.00 (-100.00%)
Price JP¥0
Share Pricen/a
Does Stella Pharma (TSE:4888) Have A Healthy Balance Sheet?
Dec 22
Stella Pharma Corporation Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
4888 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Trending Discussion
Recently Updated Narratives
No recently updated narratives available.
Snowflake Analysis
Stella Pharma Corporation Key Details
Last Reported Earnings
Dec 31, 2025
Next Reporting Earnings
n/a
- -8.20
- 87.81%
- -28.82%
- 29.2%
About 4888
- Founded
- 2007
- Employees
- 43
- CEO
- WebsiteView website
Stella Pharma Corporation engages in the research, development, manufacturing, and distribution of pharmaceuticals. The company develops drugs for boron neutron capture therapy (BNCT). Its products include SPM-011, a boron-containing drug for BNCT used for treating head and neck cancer, recurrent malignant glioma, meningioma, and malignant melanoma and angiosarcoma. The company was incorporated in 2007 and is headquartered in Osaka, Japan.
